Interact to see
Advertisement
Advertisement
MASGX vs RNWHX
MASGX vs RNWHX Comparison
Open Charts MASGX vs RNWHX
Matthews Emerging Markets Sust Fut I
Price$14.29
Change+$0.12 (+0.85%)
VolumeN/A
Net Assets217.09M
American Funds New World R5E
Price$93.87
Change+$0.03 (+0.03%)
VolumeN/A
Net Assets74.08B
MASGX vs RNWHX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
MASGX vs. RNWHX commentary
Sep 19, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MASGX is a Buy and RNWHX is a Buy.
FUNDAMENTALS
Fundamentals
RNWHX has more cash in the bank: 74.1B vs. MASGX (217M). MASGX pays higher dividends than RNWHX: MASGX (2.32) vs RNWHX (0.97). MASGX was incepted earlier than RNWHX: MASGX (10 years) vs RNWHX (10 years). MASGX (1.37) is less costly to investors than RNWHX (0.72). MASGX is a more actively managed with annual turnover of: 58.51 vs. RNWHX (37.00). RNWHX has a lower initial minimum investment than MASGX: RNWHX (250) vs MASGX (2500). RNWHX annual gain was more profitable for investors over the last year : 17.01 vs. MASGX (13.53). RNWHX return over 5 years is better than : 31.85 vs. MASGX (14.91).
| MASGX | RNWHX | MASGX / RNWHX | |
| Total Expense Ratio | 1.34 | 0.72 | 186% |
| Annual Report Gross Expense Ratio | 1.37 | 0.72 | 190% |
| Fund Existence | 10 years | 10 years | - |
| Gain YTD | 18.776 | 23.481 | 80% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 2500 | 250 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 217M | 74.1B | 0% |
| Annual Yield % from dividends | 2.32 | 0.97 | 240% |
| Returns for 1 year | 13.53 | 17.01 | 80% |
| Returns for 3 years | 16.91 | 49.85 | 34% |
| Returns for 5 years | 14.91 | 31.85 | 47% |
| Returns for 10 years | 71.71 | N/A | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| VLAAX | 41.28 | 0.08 | +0.19% |
| Value Line Asset Allocation Investor | |||
| JDEAX | 48.00 | N/A | N/A |
| JPMorgan US Research Enhanced Equity A | |||
| MBCYX | 26.20 | N/A | N/A |
| MassMutual Blue Chip Growth Svc | |||
| IGFSX | 11.25 | N/A | N/A |
| VY® Morgan Stanley Global Franchise S2 | |||
| RUSRX | 10.51 | N/A | N/A |
| Lazard US Systematic Small Cap Eq R6 | |||